Applied BioCode (TPE:6598) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6598 Applied BioCode Corp TPE:6598
75 GF Score
Price NT$26.70
GF Value NT$23.34
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Applied BioCode FFO per Share?

FFO per Share only applies to REITs.

TPE:6598
75GF Score
Applied BioCode Corp TPE:6598
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be overvalued. The current stock price of NT$26.70 is trading 14.4% above its estimated GF Value™ of NT$23.34. GuruFocus considers Applied BioCode to be Modestly Overvalued.

Key valuation signals for TPE:6598:

  • FFO per Share:
  • GF Value™: NT$23.34 vs. price of NT$26.70 (14.4% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Applied BioCode Business Description

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
75GF Score

Get the complete analysis for TPE:6598

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.70
Price
NT$23.34
GF Value